tiprankstipranks
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
PremiumPress ReleasesRelmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
1M ago
Relmada Therapeutics reports Q4 EPS (84c), consensus (83c)
PremiumThe Fly
Relmada Therapeutics reports Q4 EPS (84c), consensus (83c)
1M ago
Options Volatility and Implied Earnings Moves Today, March 19, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 19, 2024
1M ago
Here’s What You Missed in Cannabis, Psychedelics This Week
PremiumThe FlyHere’s What You Missed in Cannabis, Psychedelics This Week
2M ago
Here’s What You Missed in Cannabis, Psychedelics This Week
PremiumThe Fly
Here’s What You Missed in Cannabis, Psychedelics This Week
2M ago
Here’s What You Missed in Cannabis, Psychedelics This Week
PremiumThe Fly
Here’s What You Missed in Cannabis, Psychedelics This Week
2M ago
Rising High: Exclusive talk with house of brands Carma HoldCo
PremiumThe FlyRising High: Exclusive talk with house of brands Carma HoldCo
3M ago
Rising High: Exclusive talk with drug manufacturer Optimi Health
PremiumThe Fly
Rising High: Exclusive talk with drug manufacturer Optimi Health
3M ago
Rising High: Exclusive talk with drug manufacturer Optimi Health
PremiumThe Fly
Rising High: Exclusive talk with drug manufacturer Optimi Health
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100